JPMorgan Chase & Co., Morgan Stanley and 4 others published ratings today for Intuitive Surgical, Inc. ($ISRG) after yesterday's earnings results. Stock closed at $741.00 sliding by -1.34%
Intuitive Surgical received 9 ratings in the last 30 days, 6 of them today. Of the latest ratings, 1 were neutral or "hold" recommendations and 4 were "buy" recommendations, with no bearish or "sell" ratings.
The latest ratings were:
Calculating an average of the ratings published today, it draws a value of 1 on a scale that goes from -2 (strongly bearish) and 2 (strongly bullish), and estimating a price growth of 3.58%, from the current close at $741.00 to around $767.50
Intuitive Surgical, Inc., together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.. The stock belongs to the Medical Instruments & Supplies industry in the Healthcare sector. The firm employs 7,326 people worldwide and it's based in Sunnyvale, United States. Check for further information about the company at its corporate site at http://www.intuitive.com.
Get additional information on Intuitive Surgical ratings and price forecasts clicking here.
Advanced Micro Devices, Inc.